Possible mechanisms in the induction of pemphigus foliaceus by topical imiquimod treatment.
Mashiah
Jacob
J
Brenner
Sarah
S
D000287:Administration, Topical; D000634:Aminoquinolines / Q000009:adverse effects* / Q000627:therapeutic use; D016207:Cytokines / Q000276:immunology / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D000077271:Imiquimod; D007372:Interferons / Q000032:analysis / Q000276:immunology; D008297:Male; D010392:Pemphigus / Q000139:chemically induced* / Q000276:immunology / Q000473:pathology*; D018570:Risk Assessment; D012494:Sampling Studies
D000634:Aminoquinolines; D016207:Cytokines; D007372:Interferons; D000077271:Imiquimod